Kidswell Bio Corporation (4584.T)
JPY 102.0
(-7.27%)
JPY 102.0
(-7.27%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -453.63 Million | -1.42 Billion | -1.16 Billion | -1.26 Billion | -1.32 Million |
| Net Income | -1.42 Billion | -656.22 Million | -533.75 Million | -999.68 Million | -7.31 Million |
| Depreciation & Amortization | 921 Thousand | 932 Thousand | 2.3 Million | 992 Thousand | 382 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 993.85 Million | -951.19 Million | -322.29 Million | -237.84 Million | 221 Thousand |
| Other non-cash items | -31.72 Million | 193.03 Million | 118.95 Million | -21.44 Million | 5.77 Million |
| Investing Cash Flow | - | -28.82 Million | 526.5 Million | -22.29 Million | -137 Thousand |
| Investments in PPE | 453.63 Million | - | -160 Thousand | -3.25 Million | -1.93 Million |
| Acquisitions | - | 26.25 Million | - | -14.29 Million | 12.93 Million |
| Investment purchases | - | -50 Million | - | - | -100.34 Million |
| Sales/Maturities of investments | - | - | 526.66 Million | - | 4.72 Million |
| Other Investing Activities | - | -5.07 Million | 526 Thousand | -4.74 Million | -2.57 Million |
| Financing Cash Flow | 1.61 Billion | 1.35 Billion | 369.08 Million | 718.34 Million | 1.22 Million |
| Debt repayment | -625 Million | -1.31 Billion | - | -574.71 Million | -1.18 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 992.88 Million | 36.59 Million | 369.08 Million | 143.63 Million | 40.32 Million |
| Other Financing Activities | - | - | 369 Thousand | 1000.00 | -3.53 Million |
| Accounts receivables | 207.35 Million | -626.91 Million | 354 Thousand | -174 Thousand | -89 Thousand |
| Accounts payables | -70.42 Million | 110.08 Million | -64.25 Million | 107.39 Million | -82.31 Million |
| Inventory | -240.33 Million | 353.49 Million | -538.06 Million | -196.49 Million | -101 Thousand |
| Other working capital | 1.01 Billion | -660.85 Million | 135 Thousand | -169 Thousand | 411 Thousand |
| Cash at beginning of period | 1.06 Billion | 1.16 Billion | 1.46 Billion | 2.03 Billion | 2 Million |
| Cash at end of period | 2.23 Billion | 1.06 Billion | 1.18 Billion | 1.46 Billion | 1.76 Million |
| Capital Expenditure | 453.63 Million | - | -160 Thousand | -3.25 Million | -1.93 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 1.16 Billion | -93.77 Million | -273.96 Million | -571.41 Million | -241 Thousand |
| Free Cash Flow | - | -1.42 Billion | -1.16 Billion | -1.27 Billion | -3.26 Million |
| Breakdown | 2023 FY | 2023 Q1 | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.42 Billion | -470.62 Thousand | -656.22 Million | -533.75 Million | -999.68 Million | -7.31 Million |
| Depreciation & Amortization | 921 Thousand | - | 932 Thousand | 2.3 Million | 992 Thousand | 382 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 993.85 Million | - | -951.19 Million | -322.29 Million | -237.84 Million | 221 Thousand |
| Other non-cash items | -31.72 Million | 470.62 Thousand | 193.03 Million | 118.95 Million | -21.44 Million | 5.77 Million |
| Investing Cash Flow | - | - | -28.82 Million | 526.5 Million | -22.29 Million | -137 Thousand |
| Investments in PPE | - | - | - | -160 Thousand | -3.25 Million | -1.93 Million |
| Acquisitions | - | - | 26.25 Million | - | -14.29 Million | 12.93 Million |
| Investment purchases | - | - | -50 Million | - | - | -100.34 Million |
| Sales/Maturities of investments | - | - | - | 526.66 Million | - | 4.72 Million |
| Other Investing Activities | - | - | -5.07 Million | 526 Thousand | -4.74 Million | -2.57 Million |
| Financing Cash Flow | 1.61 Billion | - | 1.35 Billion | 369.08 Million | 718.34 Million | 1.22 Million |
| Debt repayment | -625 Million | - | -1.31 Billion | - | -574.71 Million | -1.18 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 992.88 Million | - | 36.59 Million | 369.08 Million | 143.63 Million | 40.32 Million |
| Other Financing Activities | - | - | - | 369 Thousand | 1000.00 | -3.53 Million |
| Accounts receivables | 207.35 Million | - | -626.91 Million | 354 Thousand | -174 Thousand | -89 Thousand |
| Accounts payables | -70.42 Million | - | 110.08 Million | -64.25 Million | 107.39 Million | -82.31 Million |
| Inventory | -240.33 Million | - | 353.49 Million | -538.06 Million | -196.49 Million | -101 Thousand |
| Other working capital | 1.01 Billion | - | -660.85 Million | 135 Thousand | -169 Thousand | 411 Thousand |
| Cash at beginning of period | 1.06 Billion | - | 1.16 Billion | 1.46 Billion | 2.03 Billion | 2 Million |
| Cash at end of period | 2.23 Billion | - | 1.06 Billion | 1.18 Billion | 1.46 Billion | 1.76 Million |
| Capital Expenditure | - | - | - | -160 Thousand | -3.25 Million | -1.93 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.16 Billion | - | -93.77 Million | -273.96 Million | -571.41 Million | -241 Thousand |
| Free Cash Flow | -453.63 Million | - | -1.42 Billion | -1.16 Billion | -1.27 Billion | -3.26 Million |
AS
ACUC
DMB
BSQKZ
CDP
PAAL-B